An evaluation of tumor-infiltrating lymphocytes (TILs) in GBM patients indicates that the ratio of immunosuppressive T regulatory cells to effector T cells increases in these patients, and that CTLA-4 expression is increased in these T regulatory cells. This evidence concerns the gene CTLA4 and glioblastoma.